Akari Therapeutics Plc (AKTX)
15.92
-1.88
(-10.58%)
USD |
NASDAQ |
May 27, 16:00
16.25
+0.32
(+2.04%)
After-Hours: 20:00
Akari Therapeutics Total Liabilities (Quarterly) : 19.51M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| DBV Technologies SA | 58.50M |
| Cellectis SA | 229.27M |
| Biodexa Pharmaceuticals Plc | -- |
| NuCana Plc | 6.839M |
| Autolus Therapeutics Plc | 418.24M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 33.89M |
| Shareholders Equity (Quarterly) | 14.38M |
| Debt to Equity Ratio | 0.0509 |
| Current Ratio | 0.2675 |
| Net Debt Paydown Yield | 8.58% |